Hi newB,. I think in the last quarterly update that it was mentioned that they had to do a smaller trial for LOXL2. Hopefully they will have an interested party. There is no doubt that biotechnology along with a multitude of other sectors are very high risk. I wouldn't invest in any of these companies again. Just a matter of time before I get rid of PXS. I had this written off years ago.
Ann: Pharmaxis Receives US$7m milestone from Chiesi, page-27
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
